URSODEOXYCHOLATE PROTECTS OXIDATIVE MITOCHONDRIAL METABOLISM FROM BILE-ACID TOXICITY - DOSE-RESPONSE STUDY IN ISOLATED RAT-LIVER MITOCHONDRIA

被引:66
作者
KRAHENBUHL, S
FISCHER, S
TALOS, C
REICHEN, J
机构
[1] UNIV BERN, DEPT MED, CH-3010 BERN, SWITZERLAND
[2] UNIV BERN, DEPT CLIN PHARMACOL, CH-3010 BERN, SWITZERLAND
[3] UNIV MUNICH, DEPT MED 2, D-81377 MUNICH, GERMANY
关键词
D O I
10.1002/hep.1840200632
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The effect of ursodeoxycholate and tauroursodeoxycholate on the toxicity of lipophilic bile acids (chenodeoxycholate and lithocholate) on the function of the electron transport chain was investigated in isolated rat liver mitochondria. At a concentration of 30 mu mol/L, both chenodeoxycholate and lithocholate reduced state 3 oxidation rates and respiratory control ratios of L-glutamate, succinate and duroquinol. In contrast, ADP/O ratios of these substrates and oxidative metabolism of ascorbate were not significantly affected. Ursodeoxycholate did not impair mitochondrial oxidative metabolism up to concentrations of 100 mu mol/L; at 300 mu mol/L, however, it decreased state 3 oxidation rates and respiratory control ratios of L-glutamate, succinate and duroquinol. Tauroursodeoxycholate had no significant inhibitory effect on state 3 oxidation rates of L-glutamate and succinate at concentrations up to 300 mu mol/L, When ursodeoxycholate (final concentration, 30 mu mol/L or 100 mu mol/L) was added to mitochondrial incubations containing chenodeoxycholate or lithocholate, the toxic effects of lipophilic bile acids on mitochondrial oxidative metabolism were partially reversed. However, 300 mu mol/L ursodeoxycholate, in combination with chenodeoxycholate or lithocholate, exhibited greater toxicity compared with incubations containing only the individual bile acids. In contrast to ursodeoxycholate, tauroursodeoxycholate did not reduce the toxic effects of chenodeoxycholate or lithocholate on mitochondrial metabolism. Ursodeoxycholate (100 mu mol/L) significantly decreased the incorporation of chenodeoxycholate into mitochondrial membranes, whereas the decrease in lithocholate incorporation was not statistically significant. These studies demonstrate that ursodeoxycholate, but not tauroursodeoxycholate, decreases the toxicity of lipophilic bile acids on the function of the electron transport chain up to a concentration of 100 mu mol/L but increases bile acid-induced mitochondrial toxicity at higher concentrations. The protective effect of ursodeoxycholate may partially be explained by decreased incorporation of bile acids into mitochondrial membranes.
引用
收藏
页码:1595 / 1601
页数:7
相关论文
共 39 条
[1]  
ARMITAGE P, 1987, STATISTICAL METHODS
[2]   EFFECT OF URSODEOXYCHOLIC ACID ON BILE-ACID METABOLISM IN PRIMARY BILIARY-CIRRHOSIS [J].
BATTA, AK ;
SALEN, G ;
ARORA, R ;
SHEFER, S ;
TINT, GS ;
ABROON, J ;
ESKREIS, D ;
KATZ, S .
HEPATOLOGY, 1989, 10 (04) :414-419
[3]   URSODEOXYCHOLIC ACID FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS - A PLACEBO-CONTROLLED TRIAL [J].
BEUERS, U ;
SPENGLER, U ;
KRUIS, W ;
AYDEMIR, U ;
WIEBECKE, B ;
HELDWEIN, W ;
WEINZIERL, M ;
PAPE, GR ;
SAUERBRUCH, T ;
PAUMGARTNER, G .
HEPATOLOGY, 1992, 16 (03) :707-714
[4]  
CAESTECKER JS, 1991, GUT, V32, P1061
[5]  
CHANCE B, 1959, CIBA F S REGULATION, P91
[6]   URSODEOXYCHOLIC ACID FOR PRIMARY SCLEROSING CHOLANGITIS [J].
CHAZOUILLERES, O ;
POUPON, R ;
CAPRON, JP ;
METMAN, EH ;
DHUMEAUX, D ;
AMOURETTI, M ;
COUZIGOU, P ;
LABAYLE, D ;
TRINCHET, JC .
JOURNAL OF HEPATOLOGY, 1990, 11 (01) :120-123
[7]   BILE-ACID GLYCINE AND TAURINE CONJUGATES IN SERUM OF PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS - EFFECT OF URSODEOXYCHOLIC TREATMENT [J].
CHRETIEN, Y ;
POUPON, R ;
GHERARDT, MF ;
CHAZOUILLERES, O ;
LABBE, D ;
MYARA, A ;
TRIVIN, F .
GUT, 1989, 30 (08) :1110-1115
[8]   EFFECTS OF URSODEOXYCHOLIC ACID THERAPY FOR LIVER-DISEASE ASSOCIATED WITH CYSTIC-FIBROSIS [J].
COLOMBO, C ;
SETCHELL, KDR ;
PODDA, M ;
CROSIGNANI, A ;
RODA, A ;
CURCIO, L ;
RONCHI, M ;
GIUNTA, A .
JOURNAL OF PEDIATRICS, 1990, 117 (03) :482-489
[9]   EFFECTS OF URSODEOXYCHOLIC ACID TREATMENT ON NUTRITION AND LIVER-FUNCTION IN PATIENTS WITH CYSTIC-FIBROSIS AND LONGSTANDING CHOLESTASIS [J].
COTTING, J ;
LENTZE, MJ ;
REICHEN, J .
GUT, 1990, 31 (08) :918-921
[10]  
Estabrook R., 1967, METHOD ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4